£50K Gift Funds 'Smart Virus' Brain Cancer Research

Ten years after a devastating brain tumor diagnosis, Gillian "Gilly" Lee's legacy is funding research that could save countless lives from one of cancer's most aggressive forms.

When Gilly visited her doctor in December 2015 thinking she had an ear infection, she left with a brain tumor diagnosis that would change everything. Her husband raced home from Germany, and their four children dropped everything to be by her side.

But Gilly refused to let fear define her remaining years. She dove with whale sharks in Mexico, celebrated her 30th wedding anniversary in Venice, and traveled across Europe in a van with her family. She wrote a book, raised money for brain tumor research, and inspired friends to stop postponing their dreams.

"Several people I know have stopped putting off doing something they really wanted to do," Gilly wrote in her book "The Other Days." "They call it: The Gilly Factor."

Gilly passed away peacefully in December 2019 surrounded by her loved ones. Now, her family has donated £50,000 in her name to The Brain Tumour Charity to fund Dr. Emily Bates' revolutionary work on "smart viruses."

Dr. Bates' team at Cardiff University is developing viruses that act like Trojan horses, sneaking into tumor cells to deliver powerful immunotherapy treatments from the inside. These modified viruses target only cancer cells while leaving healthy brain tissue completely unharmed.

The research focuses on glioblastoma, one of the deadliest brain cancers. Traditional treatments often work against the immune system, causing brutal side effects. Dr. Bates' approach awakens the body's natural defenses instead, helping immune cells recognize and fight the tumor.

The Ripple Effect

Gilly's husband Christian sees the donation as continuing her spirit of living fully and helping others. "Immunotherapy works with your body and immune system, whereas in the past, treatments only seemed to work against your immune system," he explains.

The research is already advancing toward clinical trials, bringing new treatment options closer to patients who desperately need them. Brain tumors remain one of the least researched and most underfunded cancers, making gifts like this critical for progress.

Dr. Bates credits The Brain Tumour Charity not just for funding, but for connecting her with a network of dedicated researchers working toward the same goal: kinder, safer, more effective treatments.

Gilly's gift ensures that others facing the same terrifying diagnosis might have options she didn't, turning her courage into concrete hope for the future.